Legal Representation
Attorney
Christina M. Licursi
USPTO Deadlines
Application History
38 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 25, 2022 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Jul 25, 2022 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Dec 14, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Dec 13, 2021 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Dec 2, 2021 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Dec 13, 2021 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Dec 2, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 19, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jun 17, 2021 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Jun 17, 2021 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Jun 17, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Dec 16, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Dec 14, 2020 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Dec 14, 2020 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Dec 14, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 19, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jun 17, 2020 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Jun 17, 2020 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Jun 17, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Dec 18, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Dec 16, 2019 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Dec 16, 2019 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Dec 16, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 18, 2019 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Apr 23, 2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Apr 23, 2019 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Apr 3, 2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Mar 18, 2019 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Feb 25, 2019 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Feb 23, 2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Feb 22, 2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Feb 22, 2019 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Dec 31, 2018 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Dec 31, 2018 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Dec 31, 2018 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Dec 31, 2018 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Nov 28, 2018 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Nov 8, 2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Detailed Classifications
Class 005
encapsulated nucleic acids for use as biological therapeutics in gene therapy for the treatment of rare genetic disorders, cardiovascular diseases, respiratory diseases, infectious diseases, retinal diseases, metabolic disorders, hormonal deficiencies, endocrine diseases, eye diseases and disorders, intestinal diseases, autoimmune/autoinflammatory diseases, inflammatory disorders, musculoskeletal diseases, neurological disorders, hematologic conditions, cutaneous conditions, neurodegenerative diseases, congenital disorders, kidney and urinary diseases, reproductive diseases, mitochondrial diseases, lung disorders, immune system diseases, mouth diseases, digestive diseases
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THERAPEUTICS"